Antacid
Medications Market |
Antacid medications are used to counteract the acid in the stomach and can be bought without a prescription at many pharmacies and shops. They can quickly relieve symptoms of reflux disease and heartburn. They do not treat the underlying cause and long-term use is not recommended. Various different types of antacid are available, including salts of magnesium, aluminium, and calcium. Sodium bicarbonate, which is found in some popular brands of antacids such as Alka-Seltzer and Bromo Seltzer, raises the gastric pH, and can also help to heal peptic ulcers.
However, it is not suitable for pregnant women and people who have high blood pressure or kidney disease as it may increase their salt intake to dangerous levels. It can also have mild laxative or constipating effects. Other antacids form a gel on the surface of the stomach which can stop acid flowing into the oesophagus and some contain simethicone to reduce bloating by helping to break down gas bubbles in the gut. The effectiveness of these ingredients varies between preparations.
Market Dynamics:
Rising product launches are estimated to augment the growth of the global
Antacid Medications Market during the forecast period. For instance, Dr. Reddy's Laboratories introduced Clidinium Bromide, and Generic Chlordiazepoxide Hydrochloride in Augidt 2022, in the US market. These capsules can be used for treating stomach ulcers, colon inflammation, and irritable bowel syndrome. Moreover, rising complications of antacids and the rising cost are anticipated to restrain the growth of the global antacid medications market during the forecast period.
Impact of COVID-19:
The pandemic led to a decline in demand and production of several products. This resulted in increasing prices, as compared to the usual. Initially, during the pandemic, there was a transient spike in the sale of antacids. This caused panic buying among consumers suffering from obesity and gastroesophageal reflux disease. Another factor that led to increasing demand for antacid medications was that some gastrointestinal medications successfully enhanced the clinical results of patients suffering from COVID-19. This had a positive impact on the growth of the global Antacid Medications Market.
Key Takeaways:
The global Antacid Medications Market is expected to witness robust growth, exhibiting a CAGR of 3.7 % over the forecast period, due to increasing product approvals. For instance, Zydus Life Sciences gained final approval from the US FDA for marketing Famotidine tablets, in June 2022. These tablets reduce the amount of acid in the stomach and are available in 40 and 20 mg.
North America is anticipated to witness robust growth in the global antacid medications market during the forecast period, due to growing initiatives by pharmaceutical organizations and the rising geriatric population.
Key players active in the global Antacid Medications Market are Reckitt Benckiser Group PLC, Pfizer Inc, Procter & Gamble, F. Hoffmann-La Roche Ltd, Aurobindo Pharma, Mylan N.V., Cipla Inc., Fresenius Kabi AG, Lupin, Hikma Pharmaceuticals PLC, Sun Pharmaceutical Industries Ltd, Novartis AG, Bayer AG, Teva Pharmaceutical Industries Ltd., GSK Plc., and Bristol Myers Squibb Company.
Comments
Post a Comment